Scopolamine Market is Estimated to Witness High Growth Owing to Rising Prevalence of Motion Sickness
Scopolamine is an anticholinergic alkaloid which blocks muscarinic acetylcholine receptors in the brain. It is used to prevent or treat nausea, vomiting, and dizziness caused by motion sickness. Scopolamine patches and gum are commonly used behind the ear or under the nose. The global scopolamine market is estimated to be valued at US$ 3676.85 Bn  in 2023 and is expected to exhibit a CAGR...
0 Comments 0 Shares 575 Views 0 Reviews
Sponsored